← back to search

Pinkus Tober‐Lau

Charité - Universitätsmedizin Berlin · DE
Area of research
Infectious Diseases · Neurology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19, and Vaccine Coverage and Hesitancy.
h-index
25
citations
2,712
works
79
NIH funding
primary concept
Medicine
email

Recent publications

Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study
The Lancet Infectious Diseases 2025cited by 20position: middledoi
A metabolite-based resistance mechanism against malaria
Science 2025cited by 8position: middledoi
Severe imported <i>Plasmodium falciparum</i> malaria with hyperparasitaemia: evaluation of determinants of critical disease in adult returning travellers
Journal of Travel Medicine 2025cited by 4position: middledoi
Glycan microarray analysis of <i>Candida</i> -related antibodies in human and mice sera guides biomarker discovery and vaccine development
Proceedings of the National Academy of Sciences 2025cited by 1position: middledoi
The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation
Cell 2024cited by 27position: middledoi
Clinical spectrum and long-term outcomes of mpox: a cohort study spanning from acute infection to six-month follow-up
BMC Infectious Diseases 2024cited by 16position: middledoi
<i>Klebsiella pneumoniae</i> Glycoconjugate Vaccine Leads Based on Semi‐Synthetic O1 and O2ac Antigens
Angewandte Chemie International Edition 2024cited by 3position: middledoi
Oxonium ion scanning mass spectrometry for large-scale plasma glycoproteomics
Nature Biomedical Engineering 2023cited by 28position: middledoi
Hepatobiliary long-term consequences of COVID-19: dramatically increased rate of secondary sclerosing cholangitis in critically ill COVID-19 patients
Hepatology International 2023cited by 23position: middledoi
Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19
JCI Insight 2023cited by 6position: middledoi
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
Nature Medicine 2022cited by 430position: middledoi
SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns
Cell Host & Microbe 2022cited by 85position: middledoi
Monkeypox in-patients with severe anal pain
Infection 2022cited by 64position: middledoi
A multiplex protein panel assay for severity prediction and outcome prognosis in patients with COVID-19: An observational multi-cohort study
EClinicalMedicine 2022cited by 34position: middledoi
Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage
The Lancet Infectious Diseases 2022cited by 33position: middledoi
Pharmacokinetics of Nirmatrelvir and Ritonavir in COVID-19 Patients with End-Stage Renal Disease on Intermittent Hemodialysis
Antimicrobial Agents and Chemotherapy 2022cited by 33position: middledoi
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease
RMD Open 2022cited by 28position: middledoi
Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens
The Journal of Experimental Medicine 2022cited by 26position: middledoi
Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study
Infection 2022cited by 15position: middledoi
Functional limitations 12 months after SARS-CoV-2 infection correlate with initial disease severity: An observational study of cardiopulmonary exercise capacity testing in COVID-19 convalescents
Respiratory Medicine 2022cited by 10position: middledoi
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
The Lancet Respiratory Medicine 2021cited by 355position: middledoi
Complement activation induces excessive T cell cytotoxicity in severe COVID-19
Cell 2021cited by 227position: middledoi
A serum proteome signature to predict mortality in severe COVID-19 patients
Life Science Alliance 2021cited by 105position: middledoi
Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers
The Lancet Respiratory Medicine 2021cited by 85position: firstdoi
Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis
Frontiers in Immunology 2021cited by 59position: middledoi
Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study
Clinical Microbiology and Infection 2021cited by 18position: middledoi
Brain magnetic resonance imaging in imported malaria
Malaria Journal 2019cited by 12position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Florian Kurth · Swiss Center for Electronics and Microtechnology (Switzerland)19 papers (2019–2025)Leif Erik Sander · Charité - Universitätsmedizin Berlin14 papers (2021–2025)Tilman Lingscheid · Humboldt-Universität zu Berlin7 papers (2022–2025)David Hillus · Humboldt-Universität zu Berlin7 papers (2021–2025)Victor M. Corman · Humboldt-Universität zu Berlin5 papers (2021–2024)Florian Klein · Chirurgische Universitätsklinik Heidelberg5 papers (2021–2023)Kanika Vanshylla · Johnson & Johnson (Netherlands)5 papers (2021–2023)Elisa T. Helbig · Charité - Universitätsmedizin Berlin4 papers (2022–2023)Henning Gruell · Bernhard Nocht Institute for Tropical Medicine4 papers (2021–2022)Thomas Zöller · Humboldt-Universität zu Berlin4 papers (2022–2025)Martin Witzenrath · German Centre for Cardiovascular Research4 papers (2022–2023)Frieder Pfäfflin · Humboldt-Universität zu Berlin4 papers (2022–2025)Charlotte Thibeault · University of California, Los Angeles3 papers (2022–2023)Markus Ralser · University of Glasgow3 papers (2021–2023)Lena J. Lippert · Charité - Universitätsmedizin Berlin3 papers (2022–2023)Vadim Demichev · Abterra Biosciences (United States)3 papers (2021–2023)Norbert Suttorp · German Center for Lung Research3 papers (2021–2022)Tatjana Schwarz · Humboldt-Universität zu Berlin3 papers (2021–2022)Friederike Münn · Humboldt-Universität zu Berlin3 papers (2022–2023)Michael Mülleder · Humboldt-Universität zu Berlin2 papers (2022–2023)